(UIMI) UBS (Lux) Fund Solutions - - Ratings and Ratios
Exchange: XETRA • Country: Germany • Currency: EUR • Type: Etf • ISIN: LU0480132876 • Global Emerging Markets Equity
UIMI: Equities, Emerging Markets, ETF, Stocks, Investments, Funds
UBS (Lux) Fund Solutions - MSCI Emerging Markets UCITS ETF, trading under the ticker symbol UIMI on XETRA, offers investors exposure to emerging markets through a UCITS-compliant framework. As a Luxembourg-domiciled ETF, it benefits from the UCITS framework, which is widely recognized for its robust regulatory standards and cross-border distribution capabilities within Europe.
Managed by UBS Asset Management, this ETF is designed to replicate the performance of the MSCI Emerging Markets Index, a widely followed benchmark for emerging market equities. The fund provides diversification across a broad range of emerging market countries, sectors, and companies, making it a key component for portfolios seeking exposure to growth opportunities in less developed markets.
With an AUM of 4,412.95 million EUR, the ETF demonstrates significant scale, which often contributes to tighter bid-ask spreads and higher liquidity. This makes it an attractive option for both institutional and retail investors. The funds trading volume and liquidity are important considerations for investors seeking efficient entry and exit points.
For fund managers and investors, understanding the ETFs structure, underlying index, and market dynamics is crucial. The MSCI Emerging Markets Index includes large- and mid-cap companies across various emerging market countries, providing a balanced representation of the growth potential in these regions. The ETFs UCITS compliance ensures transparency, regulatory oversight, and investor protection, aligning with the standards expected by European investors.
Additional Sources for UIMI ETF
UIMI ETF Overview
Market Cap in USD | 4,785m |
Category | Global Emerging Markets Equity |
TER | 0.20% |
IPO / Inception | 2010-11-12 |
UIMI ETF Ratings
Growth 5y | 43.1% |
Fundamental | - |
Dividend | 51.6% |
Rel. Strength Industry | -12.5 |
Analysts | - |
Fair Price Momentum | 95.78 EUR |
Fair Price DCF | - |
UIMI Dividends
Dividend Yield 12m | 2.58% |
Yield on Cost 5y | 3.97% |
Annual Growth 5y | 2.45% |
Payout Consistency | 93.5% |
UIMI Growth Ratios
Growth Correlation 3m | 29.5% |
Growth Correlation 12m | 80.7% |
Growth Correlation 5y | 24.7% |
CAGR 5y | 9.04% |
CAGR/Max DD 5y | 0.34 |
Sharpe Ratio 12m | 0.96 |
Alpha | 2.63 |
Beta | 0.66 |
Volatility | 17.44% |
Current Volume | 2.5k |
Average Volume 20d | 5.7k |
As of March 14, 2025, the stock is trading at EUR 100.41 with a total of 2,543 shares traded.
Over the past week, the price has changed by -2.02%, over one month by -4.76%, over three months by -2.33% and over the past year by +9.21%.
Partly, yes. Based on ValueRay Analyses, UBS (Lux) Fund Solutions - (XETRA:UIMI) is currently (March 2025) ok to buy, but has to be watched. It has a Growth Technical Rating of 43.08 and therefor an somewhat technical positive rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of UIMI as of March 2025 is 95.78. This means that UIMI is currently overvalued and has a potential downside of -4.61%.
UBS (Lux) Fund Solutions - has no consensus analysts rating.
According to ValueRays Forecast Model, UIMI UBS (Lux) Fund Solutions - will be worth about 106.2 in March 2026. The stock is currently trading at 100.41. This means that the stock has a potential upside of +5.79%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 106.2 | 5.8% |